[1]P.
Prandoni,
A.
Falanga,
A.
Piccioli.
Cancer and venous thromboembolism.
Lancet Oncol 2005; 6(6):401-410.
[2]H.
T.
Sorensen,
L.
Mellemkjaer,
J.
H.
Olsenet al.
Prognosis of cancers associated with venous thromboembolism.
N Engl J Med 2000; 343(25):1846-1850.
[3]A.
A.
Khorana,
C.
W.
Francis,
E.
Culakovaet al.
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.
J Thromb Haemost 2007; 5(3):632-634.
[4]F.
Dentali,
W.
Ageno,
C.
Becattiniet al.
Prevalence and clinical history of incidental,
asymptomatic pulmonary embolism: a meta-analysis.
Thromb Res 2010; 125(6):518-522.
[5]A.
A.
Khorana,
C.
O'Connell,
G.
Agnelliet al.
Incidental venous thromboembolism in oncology patients.
J ThrombHaemost 2012; 10(12):2602-2604.
[6]M.
P.
Donadini,
F.
Dentali,
A.
Squizzatoet al.
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data.
Intern Emerg Med 2014; 9(4):375-384.
[7]J.
Trujillo-Santos,
M.
Monreal.
Management of unsuspected pulmonary embolism in cancer patients.
Expert Rev Hematol 2013; 6(1):83-88,
89.
[8]K.
M.
Pou,
J.
M.
Massaro,
U.
Hoffmannet al.
Patterns of abdominal fat distribution: the Framingham Heart Study.
Diabetes Care 2009; 32(3):481-485.
[9]P.
D.
Stein,
A.
Beemath,
R.
E.
Olson.
Obesity as a risk factor in venous thromboembolism.
Am J Med 2005; 118(9):978-980.
[10]D.
Sottier,
J.
M.
Petit,
S.
Guiuet al.
Quantification of the visceral and subcutaneous fat by computed tomography: interobserver correlation of a single slice technique.
Diagn Interv Imaging 2013; 94(9):879-884.
[11]C.
Aoqui,
L.
Cuppari,
M.
A.
Kamimuraet al.
Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease.
Eur J Clin Nutr 2013; 67(6):610-614.
[12]T.
Yoshizumi,
T.
Nakamura,
M.
Yamaneet al.
Abdominal fat: standardized technique for measurement at CT.
Radiology 1999; 211(1):283-286.
[13]M.
A.
Kamimura,
J.
J.
Carrero,
M.
E.
Canzianiet al.
Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients.
Nutr Metab Cardiovasc Dis 2013; 23(9):891-897.
[14]M.
Dutia,
R.
H.
White,
T.
Wun.
Risk assessment models for cancer-associated venous thromboembolism.
Cancer 2012; 118(14):3468-3476.
[15] J.
C.
Seidell,
C.
J.
Bakker,
K.
van der Kooy.
Imaging techniques for measuring adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic resonance.
Am J ClinNutr 1990; 51(6):953-95.
[16]H.
Katsuyama,
A.
Kawaguchi,
H.
Yanai.
Not visceral fat area but the ratio of visceral to subcutaneous fat area is significantly correlated with the marker for atherosclerosis in obese subjects.
Int J Cardiol 2015; 179:112-113.
[17]H.
S.
Sacks,
J.
N.
Fain.
Human epicardial adipose tissue: a review.
Am Heart J 2007; 153(6):907-917.
[18]J.
N.
Fain.
Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
Vitam Horm 2006; 74:443-477
[19]Lau DC,
Dhillon B,
Yan H,
et al.
Adipokines: molecular linksbetween obesity and atherosclerosis.
Am J Physiol Heart Circ Physiol,
2005; 288:2031–41.
[20]Prandoni P,
Falanga A,
Piccioli A.
Cancer and venous thromboembolism.
Lancet Oncol 2005;6(6):401-410.
[21]L.
M.
Wang,
Q.
L.
Duan,
F.
Yanget al.
Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis.
Int J Clin Exp Med 2014; 7(3):566-572.